Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Panacos Pharmaceuticals, Inc. (PANC)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00000.0000 (0.00%)
At close: 02:02PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/25/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -70.75
52-Week Change 33,500.00%
S&P500 52-Week Change 3-13.21%
52 Week High 30.0400
52 Week Low 30.0000
50-Day Moving Average 30.0014
200-Day Moving Average 30.0004

Share Statistics

Avg Vol (3 month) 370.81k
Avg Vol (10 day) 3202.79k
Shares Outstanding 553.64M
Implied Shares Outstanding 6N/A
Float 8N/A
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2007
Most Recent Quarter (mrq)Sep 29, 2008

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-34,568.69%

Management Effectiveness

Return on Assets (ttm)-52.62%
Return on Equity (ttm)-168.83%

Income Statement

Revenue (ttm)99k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-20.00%
Gross Profit (ttm)180k
EBITDA -33.84M
Net Income Avi to Common (ttm)-35.76M
Diluted EPS (ttm)-0.6670
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)26.89M
Total Cash Per Share (mrq)0.5
Total Debt (mrq)18.21M
Total Debt/Equity (mrq)345.33
Current Ratio (mrq)2.15
Book Value Per Share (mrq)0.10

Cash Flow Statement

Operating Cash Flow (ttm)-31.15M
Levered Free Cash Flow (ttm)-16.93M
Advertisement
Advertisement